Melinta Therapeutics Inc (MLNTQ)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2019 | 06-2019 | 03-2019 | 12-2018 | 09-2018 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -276,094 | -62,712 | -26,532 | -157,192 | -113,072 |
| Depreciation Amortization | 12,684 | 8,421 | 4,474 | 16,901 | 12,887 |
| Accounts receivable | 3,552 | 3,404 | 7,593 | -5,044 | -21,463 |
| Accounts payable and accrued liabilities | -7,774 | -10,901 | -8,372 | 8,285 | 7,782 |
| Other Working Capital | -7,834 | -12,370 | -12,924 | -49,732 | -67,934 |
| Other Operating Activity | 185,647 | 11,161 | -1,560 | 15,237 | 11,090 |
| Operating Cash Flow | $-89,819 | $-62,997 | $-37,321 | $-171,545 | $-170,710 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -12 | -12 | -12 | -1,690 | -1,443 |
| Net Acquisitions | N/A | N/A | N/A | -166,382 | -166,383 |
| Purchase Sale Intangibles | -1,209 | -1,209 | -1,209 | -2,000 | -2,000 |
| Other Investing Activity | -1,209 | -1,209 | -1,209 | -2,000 | -2,000 |
| Investing Cash Flow | $-1,221 | $-1,221 | $-1,221 | $-170,072 | $-169,826 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 75,000 | 75,000 | 75,000 | 112,893 | 112,893 |
| Debt Repayment | 0 | 0 | N/A | -47,609 | -47,609 |
| Common Stock Issued | 8 | 8 | 8 | 239,992 | 239,992 |
| Other Financing Activity | -2,255 | -2,255 | -1,373 | -10,238 | -9,332 |
| Financing Cash Flow | $72,753 | $72,753 | $73,635 | $295,038 | $295,944 |
| Beginning Cash Position | 82,008 | 82,008 | 82,008 | 128,587 | 128,587 |
| End Cash Position | 63,721 | 90,543 | 117,101 | 82,008 | 83,995 |
| Net Cash Flow | $-18,287 | $8,535 | $35,093 | $-46,579 | $-44,592 |
| Free Cash Flow | |||||
| Operating Cash Flow | -89,819 | -62,997 | -37,321 | -171,545 | -170,710 |
| Capital Expenditure | -12 | -12 | -12 | -1,690 | -1,443 |
| Free Cash Flow | -89,831 | -63,009 | -37,333 | -173,235 | -172,153 |